These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Diagnostic performance and prognostic value of preoperative Chen S; Zhao Y; Tang Q; Wu C; Wang A; Ma L; Zhang X; Chen J; Gao Y; Liao X; Feng N; Fan Y; Zhang J; Li X; Liu M Cancer Imaging; 2022 Nov; 22(1):65. PubMed ID: 36435856 [TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
9. 2-[ Zhao Y; Wu C; Li W; Chen X; Li Z; Liao X; Cui Y; Zhao G; Liu M; Fu Z Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):570-579. PubMed ID: 32814979 [TBL] [Abstract][Full Text] [Related]
10. A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET/CT in renal cell carcinoma. Guo C; Liu Y; Yang H; Xia Y; Li X; Chen L; Feng Y; Zhang Y; Chen Y; Huang Z Br J Radiol; 2024 Mar; 97(1156):859-867. PubMed ID: 38290775 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of renal cell carcinoma histological subtype and fuhrman grade using Nakajima R; Nozaki S; Kondo T; Nagashima Y; Abe K; Sakai S Eur Radiol; 2017 Nov; 27(11):4866-4873. PubMed ID: 28523353 [TBL] [Abstract][Full Text] [Related]
12. Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report. Namura K; Minamimoto R; Yao M; Makiyama K; Murakami T; Sano F; Hayashi N; Tateishi U; Ishigaki H; Kishida T; Miura T; Kobayashi K; Noguchi S; Inoue T; Kubota Y; Nakaigawa N BMC Cancer; 2010 Dec; 10():667. PubMed ID: 21129184 [TBL] [Abstract][Full Text] [Related]
14. 68Ga-PSMA PET/CT and 18F-FDG PET/CT in Renal Cell Carcinoma. Chen EJ; Tan TH; Chew MT; Chye PC Clin Nucl Med; 2020 Jul; 45(7):e317-e319. PubMed ID: 32404702 [TBL] [Abstract][Full Text] [Related]
15. Comparison of 68Ga-PSMA-HBED-CC and 18F-FDG PET/CT in the Evaluation of Adenoid Cystic Carcinoma-A Prospective Study. Shamim SA; Kumar N; Arora G; Kumar D; Pathak A; Thakkar A; Sikka K; Singh CA; Kakkar A; Bhalla AS Clin Nucl Med; 2023 Nov; 48(11):e509-e515. PubMed ID: 37812520 [TBL] [Abstract][Full Text] [Related]
16. Noninvasive evaluation of tumor immune microenvironment in patients with clear cell renal cell carcinoma using metabolic parameter from preoperative 2-[ Wu C; Cui Y; Liu J; Ma L; Xiong Y; Gong Y; Zhao Y; Zhang X; Chen S; He Q; Zhang J; Liu M; Fan Y Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4054-4066. PubMed ID: 33978830 [TBL] [Abstract][Full Text] [Related]
17. The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison. Tariq A; Kwok M; Pearce A; Rhee H; Kyle S; Marsh P; Raveenthiran S; Wong D; McBean R; Westera J; Dunglison N; Esler R; Navaratnam A; Yaxley JW; Thomas P; Pattison DA; Roberts MJ Urol Oncol; 2022 Feb; 40(2):66.e1-66.e9. PubMed ID: 34895817 [TBL] [Abstract][Full Text] [Related]
18. Elevated tumor-to-liver standardized uptake value ratio (TLR) from preoperative Wu C; Cui Y; Zhao Y; Chen X; Liao X; Di L; Yin L; Liu M; Wang R Eur J Radiol; 2020 Oct; 131():109218. PubMed ID: 32882538 [TBL] [Abstract][Full Text] [Related]
19. Parghane RV; Basu S J Nucl Med Technol; 2023 Sep; 51(3):261-262. PubMed ID: 36041875 [TBL] [Abstract][Full Text] [Related]
20. Special issue "The advance of solid tumor research in China": 68Ga-PSMA-11 PET/CT for evaluating primary and metastatic lesions in different histological subtypes of renal cell carcinoma. Li Y; Zheng R; Zhang Y; Huang C; Tian L; Liu R; Liu Y; Zhang Z; Han H; Zhou F; He L; Dong P Int J Cancer; 2023 Jan; 152(1):42-50. PubMed ID: 35751420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]